Latest News
19 May 2015 Abzena to provide Apitope with Analytical Support for Development of a Novel Treatment for Factor VIII Inhibitors in Haemophilia A Patients Read More
Upcoming Events
27th - 28th May Americas Antibody / World Biosimilar Congress
San Diego, USA

Abzena offers a suite of complementary services and technologies through its subsidiaries, PolyTherics and Antitope, to enable the development of better biopharmaceuticals which will have a greater chance of reaching the market.


Privacy & cookie policy
© Abzena plc, 2014. All rights reserved.